nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—Passive transport by Aquaporins—AQP4—amyotrophic lateral sclerosis	0.0576	0.167	CbGpPWpGaD
Acetazolamide—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.0387	0.097	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.0294	0.0854	CbGpPWpGaD
Acetazolamide—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0224	0.0562	CcSEcCtD
Acetazolamide—AQP1—Vasopressin regulates renal water homeostasis via Aquaporins—AQP4—amyotrophic lateral sclerosis	0.0208	0.0603	CbGpPWpGaD
Acetazolamide—AQP1—Aquaporin-mediated transport—AQP4—amyotrophic lateral sclerosis	0.0181	0.0526	CbGpPWpGaD
Acetazolamide—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0445	CcSEcCtD
Acetazolamide—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.017	0.0427	CcSEcCtD
Acetazolamide—CA1—nerve—amyotrophic lateral sclerosis	0.0164	0.0639	CbGeAlD
Acetazolamide—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0378	CcSEcCtD
Acetazolamide—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.015	0.0376	CcSEcCtD
Acetazolamide—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0347	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0341	CcSEcCtD
Acetazolamide—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0332	CcSEcCtD
Acetazolamide—CA4—nerve—amyotrophic lateral sclerosis	0.0129	0.0499	CbGeAlD
Acetazolamide—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0311	CcSEcCtD
Acetazolamide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.012	0.0301	CcSEcCtD
Acetazolamide—AQP1—medulla oblongata—amyotrophic lateral sclerosis	0.012	0.0465	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.0115	0.0334	CbGpPWpGaD
Acetazolamide—AQP1—spinal cord—amyotrophic lateral sclerosis	0.0107	0.0414	CbGeAlD
Acetazolamide—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0261	CcSEcCtD
Acetazolamide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00967	0.0243	CcSEcCtD
Acetazolamide—CA4—hindbrain—amyotrophic lateral sclerosis	0.00963	0.0374	CbGeAlD
Acetazolamide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00959	0.0241	CcSEcCtD
Acetazolamide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00946	0.0238	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.00936	0.0272	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.00926	0.0269	CbGpPWpGaD
Acetazolamide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00906	0.0227	CcSEcCtD
Acetazolamide—AQP1—nervous system—amyotrophic lateral sclerosis	0.00899	0.0349	CbGeAlD
Acetazolamide—AQP1—central nervous system—amyotrophic lateral sclerosis	0.00865	0.0336	CbGeAlD
Acetazolamide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00861	0.0216	CcSEcCtD
Acetazolamide—AQP1—cerebellum—amyotrophic lateral sclerosis	0.00846	0.0329	CbGeAlD
Acetazolamide—CA2—hindbrain—amyotrophic lateral sclerosis	0.00798	0.031	CbGeAlD
Acetazolamide—CA14—medulla oblongata—amyotrophic lateral sclerosis	0.00797	0.0309	CbGeAlD
Acetazolamide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00776	0.0195	CcSEcCtD
Acetazolamide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00735	0.0185	CcSEcCtD
Acetazolamide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00728	0.0183	CcSEcCtD
Acetazolamide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0179	CcSEcCtD
Acetazolamide—CA14—spinal cord—amyotrophic lateral sclerosis	0.0071	0.0276	CbGeAlD
Acetazolamide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00709	0.0178	CcSEcCtD
Acetazolamide—AQP1—brain—amyotrophic lateral sclerosis	0.00687	0.0267	CbGeAlD
Acetazolamide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00687	0.0172	CcSEcCtD
Acetazolamide—CA7—cerebellum—amyotrophic lateral sclerosis	0.00676	0.0263	CbGeAlD
Acetazolamide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00667	0.0167	CcSEcCtD
Acetazolamide—CA3—nervous system—amyotrophic lateral sclerosis	0.00659	0.0256	CbGeAlD
Acetazolamide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00652	0.0164	CcSEcCtD
Acetazolamide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00647	0.0162	CcSEcCtD
Acetazolamide—Shock—Riluzole—amyotrophic lateral sclerosis	0.00636	0.016	CcSEcCtD
Acetazolamide—CA3—central nervous system—amyotrophic lateral sclerosis	0.00635	0.0247	CbGeAlD
Acetazolamide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00633	0.0159	CcSEcCtD
Acetazolamide—CA9—cerebellum—amyotrophic lateral sclerosis	0.00594	0.0231	CbGeAlD
Acetazolamide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00581	0.0146	CcSEcCtD
Acetazolamide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00575	0.0144	CcSEcCtD
Acetazolamide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00569	0.0143	CcSEcCtD
Acetazolamide—CA14—cerebellum—amyotrophic lateral sclerosis	0.00563	0.0219	CbGeAlD
Acetazolamide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00562	0.0141	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00558	0.014	CcSEcCtD
Acetazolamide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00558	0.014	CcSEcCtD
Acetazolamide—CA4—brainstem—amyotrophic lateral sclerosis	0.00552	0.0214	CbGeAlD
Acetazolamide—CA7—brain—amyotrophic lateral sclerosis	0.00549	0.0213	CbGeAlD
Acetazolamide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00533	0.0134	CcSEcCtD
Acetazolamide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00514	0.0129	CcSEcCtD
Acetazolamide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00511	0.0128	CcSEcCtD
Acetazolamide—CA3—brain—amyotrophic lateral sclerosis	0.00504	0.0196	CbGeAlD
Acetazolamide—CA2—embryo—amyotrophic lateral sclerosis	0.00499	0.0194	CbGeAlD
Acetazolamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—amyotrophic lateral sclerosis	0.00483	0.014	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.00479	0.0139	CbGpPWpGaD
Acetazolamide—CA12—nervous system—amyotrophic lateral sclerosis	0.00467	0.0181	CbGeAlD
Acetazolamide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00464	0.0116	CcSEcCtD
Acetazolamide—CA14—brain—amyotrophic lateral sclerosis	0.00458	0.0178	CbGeAlD
Acetazolamide—CA2—brainstem—amyotrophic lateral sclerosis	0.00457	0.0178	CbGeAlD
Acetazolamide—AQP1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00456	0.0133	CbGpPWpGaD
Acetazolamide—CA12—central nervous system—amyotrophic lateral sclerosis	0.00449	0.0175	CbGeAlD
Acetazolamide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00442	0.0111	CcSEcCtD
Acetazolamide—CA1—spinal cord—amyotrophic lateral sclerosis	0.00439	0.0171	CbGeAlD
Acetazolamide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0107	CcSEcCtD
Acetazolamide—CA5B—nervous system—amyotrophic lateral sclerosis	0.00419	0.0163	CbGeAlD
Acetazolamide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00411	0.0103	CcSEcCtD
Acetazolamide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0102	CcSEcCtD
Acetazolamide—CA5B—central nervous system—amyotrophic lateral sclerosis	0.00403	0.0157	CbGeAlD
Acetazolamide—SLC22A6—brain—amyotrophic lateral sclerosis	0.00398	0.0155	CbGeAlD
Acetazolamide—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.00385	0.0149	CbGeAlD
Acetazolamide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00964	CcSEcCtD
Acetazolamide—CA1—nervous system—amyotrophic lateral sclerosis	0.0037	0.0144	CbGeAlD
Acetazolamide—CA12—brain—amyotrophic lateral sclerosis	0.00357	0.0139	CbGeAlD
Acetazolamide—CA1—central nervous system—amyotrophic lateral sclerosis	0.00356	0.0138	CbGeAlD
Acetazolamide—CA4—spinal cord—amyotrophic lateral sclerosis	0.00343	0.0133	CbGeAlD
Acetazolamide—CA5B—brain—amyotrophic lateral sclerosis	0.0032	0.0124	CbGeAlD
Acetazolamide—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.00319	0.0124	CbGeAlD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00294	0.00854	CbGpPWpGaD
Acetazolamide—CA4—nervous system—amyotrophic lateral sclerosis	0.00289	0.0112	CbGeAlD
Acetazolamide—CA2—spinal cord—amyotrophic lateral sclerosis	0.00284	0.0111	CbGeAlD
Acetazolamide—CA1—brain—amyotrophic lateral sclerosis	0.00283	0.011	CbGeAlD
Acetazolamide—AQP1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00282	0.00819	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00282	0.00819	CbGpPWpGaD
Acetazolamide—CA4—central nervous system—amyotrophic lateral sclerosis	0.00278	0.0108	CbGeAlD
Acetazolamide—CA4—cerebellum—amyotrophic lateral sclerosis	0.00272	0.0106	CbGeAlD
Acetazolamide—AQP1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00258	0.00749	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.00258	0.00749	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.0025	0.00726	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.0025	0.00726	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00245	0.0071	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00245	0.0071	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0024	0.00697	CbGpPWpGaD
Acetazolamide—CA2—nervous system—amyotrophic lateral sclerosis	0.0024	0.00931	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.00239	0.00695	CbGpPWpGaD
Acetazolamide—CA2—central nervous system—amyotrophic lateral sclerosis	0.00231	0.00896	CbGeAlD
Acetazolamide—AQP1—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.00226	0.00657	CbGpPWpGaD
Acetazolamide—CA2—cerebellum—amyotrophic lateral sclerosis	0.00226	0.00876	CbGeAlD
Acetazolamide—AQP1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00225	0.00655	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00224	0.0065	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00223	0.00647	CbGpPWpGaD
Acetazolamide—CA4—brain—amyotrophic lateral sclerosis	0.00221	0.00858	CbGeAlD
Acetazolamide—CA9—Cellular response to hypoxia—VEGFA—amyotrophic lateral sclerosis	0.00213	0.00619	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00208	0.00604	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00204	0.00592	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00195	0.00568	CbGpPWpGaD
Acetazolamide—CA2—brain—amyotrophic lateral sclerosis	0.00183	0.00712	CbGeAlD
Acetazolamide—CA9—Cellular responses to stress—GSR—amyotrophic lateral sclerosis	0.0018	0.00522	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—DAO—amyotrophic lateral sclerosis	0.00177	0.00513	CbGpPWpGaD
Acetazolamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00176	0.0051	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VCP—amyotrophic lateral sclerosis	0.00173	0.00504	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00162	0.0047	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00158	0.00458	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00158	0.00458	CbGpPWpGaD
Acetazolamide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00155	0.00601	CbGeAlD
Acetazolamide—AQP1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00155	0.00449	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00154	0.00446	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00154	0.00446	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00154	0.00446	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00154	0.00446	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.00153	0.00446	CbGpPWpGaD
Acetazolamide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00149	0.00578	CbGeAlD
Acetazolamide—CA14—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00144	0.00419	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00143	0.00416	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00143	0.00416	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00143	0.00416	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00143	0.00416	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00143	0.00414	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0014	0.00408	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0014	0.00408	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00134	0.00389	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00134	0.00389	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00133	0.00386	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00133	0.00386	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00131	0.00381	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00131	0.00381	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00131	0.00379	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00131	0.00379	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00126	0.00366	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GSR—amyotrophic lateral sclerosis	0.00124	0.00359	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00123	0.00357	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00123	0.00357	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00122	0.00354	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00122	0.00354	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00121	0.00353	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00117	0.0034	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.00117	0.00339	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00115	0.00333	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00115	0.00333	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—DAO—amyotrophic lateral sclerosis	0.00114	0.00331	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00113	0.00328	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—DAO—amyotrophic lateral sclerosis	0.00111	0.00322	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—DAO—amyotrophic lateral sclerosis	0.00111	0.00322	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00106	0.00308	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00106	0.00308	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00106	0.00308	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00105	0.00306	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—DAO—amyotrophic lateral sclerosis	0.00104	0.00301	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—DAO—amyotrophic lateral sclerosis	0.00104	0.00301	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00102	0.00295	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00102	0.00295	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00102	0.00295	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000981	0.00285	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000973	0.00283	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000973	0.00283	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000969	0.00281	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—DAO—amyotrophic lateral sclerosis	0.00096	0.00279	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000929	0.0027	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000901	0.00262	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000896	0.0026	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00089	0.00259	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000863	0.00251	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000863	0.00251	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000856	0.00249	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000856	0.00249	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000847	0.00246	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000841	0.00244	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000841	0.00244	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000831	0.00241	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000828	0.0024	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.000812	0.00236	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000812	0.00236	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000798	0.00232	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSR—amyotrophic lateral sclerosis	0.000797	0.00231	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.000793	0.0023	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000785	0.00228	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000785	0.00228	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000783	0.00227	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000778	0.00226	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000776	0.00226	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000776	0.00226	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000766	0.00222	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000734	0.00213	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000728	0.00211	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000728	0.00211	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSR—amyotrophic lateral sclerosis	0.000725	0.00211	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000725	0.00211	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000704	0.00204	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000684	0.00199	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSR—amyotrophic lateral sclerosis	0.000672	0.00195	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000654	0.0019	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000638	0.00185	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000638	0.00185	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000629	0.00183	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000619	0.0018	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000595	0.00173	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000595	0.00173	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00058	0.00169	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000578	0.00168	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000556	0.00162	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000551	0.0016	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000546	0.00159	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000536	0.00156	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000535	0.00155	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000533	0.00155	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000513	0.00149	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000501	0.00146	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000492	0.00143	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000476	0.00138	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000469	0.00136	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000455	0.00132	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000455	0.00132	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00044	0.00128	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000433	0.00126	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000422	0.00122	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00042	0.00122	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000413	0.0012	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000406	0.00118	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000404	0.00117	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000355	0.00103	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000352	0.00102	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000343	0.000995	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000343	0.000995	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000326	0.000947	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.000324	0.00094	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000323	0.000939	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00032	0.000929	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00032	0.000929	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000315	0.000915	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000315	0.000915	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000296	0.000861	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000294	0.000854	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000294	0.000854	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000283	0.000821	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000272	0.000791	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—APOE—amyotrophic lateral sclerosis	0.000266	0.000772	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—APOE—amyotrophic lateral sclerosis	0.000259	0.000753	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—APOE—amyotrophic lateral sclerosis	0.000259	0.000753	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	0.000244	0.00071	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APOE—amyotrophic lateral sclerosis	0.000242	0.000703	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APOE—amyotrophic lateral sclerosis	0.000242	0.000703	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000236	0.000687	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000227	0.000658	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	0.000224	0.000651	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000217	0.000631	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000217	0.000631	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000208	0.000605	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.0002	0.00058	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000191	0.000555	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000188	0.000546	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000185	0.000539	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000182	0.000529	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	0.000179	0.000519	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000178	0.000516	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000178	0.000516	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000176	0.00051	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000171	0.000498	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000166	0.000481	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000166	0.000481	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000164	0.000477	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000154	0.000446	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOE—amyotrophic lateral sclerosis	0.000144	0.000419	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000144	0.000418	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000144	0.000418	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000132	0.000383	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000123	0.000356	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000122	0.000356	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000117	0.000341	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000115	0.000335	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000113	0.000327	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000104	0.000303	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.89e-05	0.000287	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.89e-05	0.000229	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.29e-05	0.000212	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.98e-05	0.000174	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.22e-05	9.34e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.95e-05	8.58e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.43e-05	7.06e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.67e-05	4.84e-05	CbGpPWpGaD
